<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">URO</journal-id>
<journal-id journal-id-type="hwp">spuro</journal-id>
<journal-title>Journal of Clinical Urology</journal-title>
<issn pub-type="ppub">2051-4158</issn>
<issn pub-type="epub">2051-4166</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1875974212466357</article-id>
<article-id pub-id-type="publisher-id">10.1177_1875974212466357</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case which changed my practice</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A unique presentation of varicella-zoster neuropathy with a thoracolumbar rash and acute urinary retention</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Walkden</surname><given-names>GJ</given-names></name>
<xref ref-type="aff" rid="aff1-1875974212466357">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Ryan</surname><given-names>N</given-names></name>
<xref ref-type="aff" rid="aff2-1875974212466357">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-1875974212466357"><label>1</label>University of Bristol Medical School, UK</aff>
<aff id="aff2-1875974212466357"><label>2</label>North Bristol NHS Trust, UK</aff>
<author-notes>
<corresp id="corresp1-1875974212466357">Neil Ryan, ENT Department, Southwell Street, Bristol BS2 8EG, UK. Email: <email>neilryan@nhs.net</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2013</year>
</pub-date>
<volume>6</volume>
<issue>2</issue>
<fpage>129</fpage>
<lpage>130</lpage>
<history><date date-type="received">
<day>8</day>
<month>9</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>10</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© British Association of Urological Surgeons 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">British Association of Urological Surgeons</copyright-holder>
</permissions>
<abstract>
<p>A 47-year-old female presented to a tertiary centre with a rare case of acute urinary retention (AUR) with a concomitant vesicular rash over the thoracic region that was clinically consistent with unilateral herpes zoster reactivation.</p>
<p>Diagnosis was made by clinical examination. She was managed conservatively and discharged with oral aciclovir.</p>
</abstract>
<kwd-group>
<kwd>Varicella-zoster</kwd>
<kwd>neuropathy</kwd>
<kwd>urinary retention</kwd>
<kwd>case report</kwd>
<kwd>rash</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1875974212466357" sec-type="intro">
<title>Introduction</title>
<p>The varicella-zoster virus (VZV) is a rare cause of the commonly diagnosed condition of acute urinary retention (AUR).<sup><xref ref-type="bibr" rid="bibr1-1875974212466357">1</xref></sup> Its pathophysiology is attributed to impairment of the detrusor reflex. Clinical diagnosis is established by identification of the pathognomonic unilateral vesicular skin eruption in a dermatomal distribution. Published cases of VZV-associated AUR report sacral herpetiform rashes.</p>
<p>Here, we present a noteworthy case of AUR with an associated thoracolumbar rash, as opposed to the typical sacral distribution.</p>
</sec>
<sec id="section2-1875974212466357" sec-type="cases">
<title>The case</title>
<p>A 47-year-old female presented to a tertiary referral centre after a failed trial-without-catheter. Her initial presentation to general practice had been with a four-day history of suprapubic discomfort and hesitancy. Five days later, she presented to a minor injuries unit and was catheterised (residual volume: 1500 ml). She returned to her general practitioner, to whom she reported bilateral lower limb paraesthesia and decreased sensation in a saddle distribution. She had not defecated for seven days by the time she was admitted to tertiary care. Further examination yielded a vesicular rash on her posterior thorax consistent with active VZV. Her past medical history had included three episodes of active VZV infection.</p>
<p>She was treated with intravenous aciclovir and laxatives. On day nine, she successfully passed urine following removal of the catheter and was discharged home on the proceeding day with three days’ oral aciclovir remaining. She had no further complaints.</p>
</sec>
<sec id="section3-1875974212466357" sec-type="results">
<title>Results</title>
<p>Urinary microscopy and culture were negative. A magnetic resonance imaging (MRI) scan of the lumbosacral spine and abdominal ultrasound scan (USS) were unremarkable. Lumbar puncture (LP) was normal. The polymerase chain reaction (PCR) was negative for cytomegalovirus, Epstein-Barr virus, herpes simplex virus and VZV. The sample was not oligoclonal. Routine bloods tests were normal.</p>
</sec>
<sec id="section4-1875974212466357" sec-type="discussion">
<title>Discussion</title>
<p>Fewer than 150 cases of VZV-associated AUR have been reported worldwide. None, to the best of our knowledge, report thoracolumbar vesicles. The stereotyped distribution is sacral.</p>
<p>Primary infection is followed by a latency in which VZV colonises the dorsal root ganglia.<sup><xref ref-type="bibr" rid="bibr2-1875974212466357">2</xref></sup> Cutaneous reactivation is manifest as an erythematous vesicular macropapular rash, which is present unilaterally in at least one dermatome.<sup><xref ref-type="bibr" rid="bibr3-1875974212466357">3</xref></sup> Sensory changes such as marked allodynia often follow its resolution (postherpetic neuralgia).</p>
<p>Occasionally in immunocompetent patients, and especially in immunocompromised patients, VZV can spread to the brain and spinal cord.<sup><xref ref-type="bibr" rid="bibr2-1875974212466357">2</xref></sup> In immunocompromised hosts, the resulting myelitis or encephalitis is more protracted.</p>
<p>Three syndromes of VZV-associated bladder dysfunction are known:<sup><xref ref-type="bibr" rid="bibr4-1875974212466357">4</xref>,<xref ref-type="bibr" rid="bibr5-1875974212466357">5</xref></sup> zoster retention (presented here), zoster cystitis and zoster myelitis. All three are attributable to myelitis of sacral nerve roots 2 and 3.<sup><xref ref-type="bibr" rid="bibr6-1875974212466357">6</xref></sup> As in this case, retention commonly presents alongside constipation due to anal sphincter dysfunction.<sup><xref ref-type="bibr" rid="bibr5-1875974212466357">5</xref></sup></p>
<p>It should be noted that our cerebrospinal fluid (CSF) PCR was negative for VZV. A positive result is required for the diagnosis of VZV only in the absence of rash (Zoster <italic>sine herpete</italic>). Patients with VZV infection who exhibit dermatomal rashes and concomitant radiculitis have been shown to demonstrate positive CSF PCR for VZV in only 43% of cases.<sup><xref ref-type="bibr" rid="bibr7-1875974212466357">7</xref></sup> The mean duration between the onset of vesicular rash and LP was 6.1 days in this study. The authors demonstrated a positive PCR in 61.5% of samples harvested within seven days of rash onset, compared with just 25% of samples collected after seven days. It is therefore unsurprising that our CSF PCR was negative for VZV at 12 days after initial presentation.</p>
<p>Our management was conservative, as supported by both the literature<sup><xref ref-type="bibr" rid="bibr1-1875974212466357">1</xref>,<xref ref-type="bibr" rid="bibr6-1875974212466357">6</xref></sup> and our results. After full and normal investigations, clinicians should aim to make a diagnosis on clinical grounds utilising the pathognomonic rash, irrespective of a negative PCR result. Treatment should include catheterisation, therapeutic-dose aciclovir and follow-up urodynamic studies. Prognosis is excellent, with recovery expected within 10 weeks of presentation.<sup><xref ref-type="bibr" rid="bibr3-1875974212466357">3</xref></sup></p>
<p>We use this case to highlight the clinical nature of the diagnosis, based on a thorough history of VZV, a herpetiform rash (not limited to the lumbosacral region) and without the need for a positive PCR result.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<label>Conflict of interest</label>
<p>The authors declare that there are no conflicts of interest.</p>
</fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1875974212466357">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Acheson</surname><given-names>J</given-names></name>
<name><surname>Mudd</surname><given-names>D</given-names></name>
</person-group> <article-title>Acute urinary retention attributable to sacral herpes zoster</article-title>. <source>Emerg Med J</source> <year>2004</year>; <volume>21</volume>: <fpage>752</fpage>–<lpage>753</lpage>.</citation>
</ref>
<ref id="bibr2-1875974212466357">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gilden</surname><given-names>DH</given-names></name>
<name><surname>Kleinschmidt-DeMasters</surname><given-names>BK</given-names></name>
<name><surname>LaGuardia</surname><given-names>JJ</given-names></name>
<etal/>
</person-group>. <article-title>Neurologic complications of the reactivation of varicella-zoster virus</article-title>. <source>N Eng J Med</source> <year>2000</year>; <volume>342</volume>: <fpage>635</fpage>–<lpage>645</lpage>.</citation>
</ref>
<ref id="bibr3-1875974212466357">
<label>3.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Bradley</surname><given-names>WG.</given-names></name>
</person-group> <source>Neurology in clinical practice</source>. <edition>4th ed.</edition> <publisher-loc>Phila-delphia, PA: Oxford</publisher-loc>: <publisher-name>Butterworth-Heinemann</publisher-name>, <year>2004</year>.</citation>
</ref>
<ref id="bibr4-1875974212466357">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>P</given-names></name>
<name><surname>Hsueh</surname><given-names>H</given-names></name>
<name><surname>Hong</surname><given-names>C.</given-names></name>
</person-group> <article-title>Herpes zoster-associated voiding dysfunction: A retrospective study and literature review</article-title>. <source>Arch Phys Med Rehabil</source> <year>2002</year>; <volume>83</volume>: <fpage>1624</fpage>–<lpage>1628</lpage>.</citation>
</ref>
<ref id="bibr5-1875974212466357">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cohen</surname><given-names>LM</given-names></name>
<name><surname>Fowler</surname><given-names>JF</given-names></name>
<name><surname>Owen</surname><given-names>LG</given-names></name>
<etal/>
</person-group>. <article-title>Urinary retention associated with herpes zoster infection</article-title>. <source>Int J Dermatol</source> <year>1993</year>; <volume>32</volume>: <fpage>24</fpage>–<lpage>26</lpage>.</citation>
</ref>
<ref id="bibr6-1875974212466357">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Broseta</surname><given-names>E</given-names></name>
<name><surname>Osca</surname><given-names>J</given-names></name>
<name><surname>Morera</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>Urological manifestations of herpes zoster</article-title>. <source>Eur Urol</source> <year>1993</year>; <volume>24</volume>: <fpage>244</fpage>.</citation>
</ref>
<ref id="bibr7-1875974212466357">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gregoire</surname><given-names>S</given-names></name>
<name><surname>Van Pesch</surname><given-names>V</given-names></name>
<name><surname>Goffette</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>Polymerase chain reaction analysis and oligoclonal antibody in the cerebro- spinal fluid from 34 patients with varicella-zoster virus infection of the nervous system</article-title>. <source>J Neurol Neurosurg Psychiatry</source> <year>2006</year>; <volume>77</volume>: <fpage>938</fpage>–<lpage>942</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>